Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $.01 per share
-
Shares outstanding
-
92,303,650
-
Total 13F shares
-
93,271,335
-
Share change
-
-9,578,207
-
Total reported value
-
$7,293,955,259
-
Put/Call ratio
-
488%
-
Price per share
-
$78.18
-
Number of holders
-
310
-
Value change
-
-$736,918,242
-
Number of buys
-
155
-
Number of sells
-
136
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $.01 per share (ACHC) as of Q3 2022
As of 30 Sep 2022,
Acadia Healthcare Company, Inc. - Common Stock, par value $.01 per share (ACHC) was held by
310 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,271,335 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., VANGUARD GROUP INC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Invesco Ltd., VIKING GLOBAL INVESTORS LP, and STATE STREET CORP.
This page lists
310
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.